Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05167695
Other study ID # 2021-06-14409
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 4, 2022
Est. completion date July 1, 2026

Study information

Verified date October 2023
Source University of California, Berkeley
Contact Estephania Ovalle Patino, BA
Phone 6613127786
Email estephaniao@berkeley.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will test a sleep-health intervention that leverages the science on habit formation. It will evaluate if adding a text messaging intervention improves habit formation. The participants will be 18-30 years old.


Description:

The study will test a sleep-health intervention that leverages the science on habit formation. Additionally, the investigators will evaluate whether adding a text messaging intervention improves habit formation. The participants will be 18-30 years old. This is a distinct developmental period in which priorities shift toward self-sufficiency and personal responsibility, which are supported by developing adaptive habits. Main Aim. To evaluate if adding a text messaging intervention, derived from learning theory, to HABITs improves the utilization of sleep health behavior and improves sleep and circadian outcomes and functioning in the five health-relevant domain outcomes in the short (post-treatment) and longer term (6 and 12-months later), relative to HABITs without text messaging. Main Hypothesis. Relative to HABITs, youth in HABITs+Texts will (a) establish stronger sleep health behavior habits, (b) report utilizing more sleep health behaviors and (c) exhibit improved sleep and circadian functioning and lower health-relevant risk. These effects will be observed at post-treatment as well as 6 and 12-months later. Exploratory Aim: To evaluate if the Habit-based Sleep Health Intervention ('HABITs') is associated with an improvement in the utilization of sleep health behavior, an improvement in sleep and circadian outcomes and an improvement in functioning in the five health-relevant domain outcomes in the short (post-treatment) and longer term (6 and 12-months later), relative to baseline. Exploratory Hypothesis. Combining across the HABITs and HABITs+Texts treatment arms, receiving either intervention will be associated with (a) improved sleep health behavior habits, (b) more utilization of sleep health behaviors, (c) improved sleep and circadian functioning and (d) lower health-relevant risk at post-treatment, 6- and 12-month follow-up, relative to baseline. Additional exploratory analyses: To examine (a) if sleep health behavior that has become habitual mediates the effects of treatment on improvement in sleep, circadian and health outcomes and (b) if intervention effects are moderated by selected variables (e.g., age, sex, minority group, socioeconomic status (SES), season).


Recruitment information / eligibility

Status Recruiting
Enrollment 160
Est. completion date July 1, 2026
Est. primary completion date December 20, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: 1. Scoring less than or equal to 26 on the Composite Scale of Morningness OR Mid-point of sleep later than 4:30 AM for 18-24 yo and 3:50 AM for 25-30 yo on work-free/weekend days over the past month OR Night-to-night variation in sleep and wake times across one month of 2 hours or more. 2. 'At risk' in one of the five health domains: the emotional domain, the cognitive domain, the behavioral domain, the physical domain and the social domain. "Risk" is defined as scoring 4 or higher on one item from an adapted version of the Work and Social Adjustment Scale. 3. Age between 18 and 30. 4. English language fluency. 5. Able and willing to give informed assent. 6. If taking medication for sleep, the dose and frequency of use must have been stable for at least 4 weeks. Exclusion Criteria: 1. Presence of substance abuse/dependence, mental illness, physical illness, suicidality or developmental disorder only if it makes participation in the study unfeasible or if there is a significant risk of harm and/or decompensation if treatment of that comorbid condition is delayed due to participating in this study. 2. Evidence of sleep apnea, restless legs or periodic limb movements during sleep. Youth presenting with provisional diagnoses of any of these disorders will be referred for a non-study polysomnography evaluation and will be enrolled only if the diagnosis is disconfirmed or if the disorder is treated. 3. Night shifter worker where the shift is scheduled between the hours of midnight to 6am > 2 nights per week. 4. Pregnancy or breast-feeding.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Habit-based Sleep Health Intervention
A novel low-cost approach derived by leveraging the science of habit formation
Text messaging intervention
In addition to the Habit-based Sleep Health Intervention, the participants will also receive the text messaging intervention.

Locations

Country Name City State
United States University of California Berkeley California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Berkeley

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Adapted version of the Work and Social Adjustment Scale (individual items) A measure of emotional, cognitive, physical, social and behavioral risk. The 5 items are each rated on a 0-8 scale. The 5 individual item scores will be reported separately (range: 0 to 8; Higher score means worse outcome). Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Self Report Habit Index: Secondary habit bundle to build 1 item rated on 1-5 scale. Scores can range from 1 to 5 At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Self Report Habit Index: Secondary habit bundle to dismantle 1 items rated on 1-5 scale. Scores can range from 1 to 5 At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Height (cm) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Weight Pounds (lbs) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Hip circumference (cm) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Waist circumference (cm) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Sleep Diary (Not a scale); Consensus sleep diary variables, including total sleep time, bedtime, and wake-time, calculated separately for weekdays and weekends. Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Actigraphy (Not a scale); Sleep parameters, including sleep onset time, sleep offset time, and total sleep time, calculated separately for weekdays and weekends. Change from baseline to 1-week post treatment
Other Sussex-Oxford Compassion Scale (SOCS) Sum of 20-item, 5-point response scale. Scores can range from 20 to 100 (Higher score means higher compassion for self).
Sub-scale items included.
Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Suicidal Behavior Questionnaire - Revised 4-item. Total scores can range from 3-18 (Higher Score means higher Suicidal ideation)
Sub-scale items included.
Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Alexian Brothers Urge to Self Injure Scale 5-item. 0-6 point scale. Total scores can range from 0-30 (Higher Score means higher Suicidal ideation) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other State authenticity A measure of state authenticity. The 4 items are each rated on a 1-7 scale. The sum is averaged (range 1-7; higher scores mean more authenticity) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Other Past month estimates of sleep mid-point workfree days and night-to-night sleep variability Questions to assess mid-point and night-to-night variability eligibility criteria Once at baseline
Other Sleep Medication Log Questions to assess use of medications Once at baseline
Other Credibility Expectancy Questionnaire first 3 items are on a 1-9 scale. The final item is on a 0-100 scale. (Higher score means the treatment was evaluated as more credible). After the 2nd treatment session, which is 2 to 3 weeks after the beginning of treatment. Again at the post-treatment assessment which is 1-week post treatment
Other Adverse Events Checklist 16 items to assess adverse events experienced during treatment At the 1-week post treatment assessment only
Other Proportion of text messages read 1 item rated from 0% to 100% At the 1-week post treatment assessment only
Other Script Elicitation Worksheet (Not a scale); Individualized for each patient, the worksheet includes primary and secondary habit bundles to build and dismantle (e.g., sleep-onset habits, WASO habits, rise-up habits, daytime habits, sleep efficiency habits), and strategy to dismantle primary and secondary habit bundles (e.g., substitution, removing or curtailing, reorganizing) After starting treatment, at the end of the 1st through 3rd treatment session (week 1 through week 3 of treatment)
Primary Self-Report Automaticity Habits Index integrated with the Utilization Scale 16-item; 0-4 scale. Scores can range from 0 to 64 (Higher score means more automaticity in utilization). Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Primary Utilization Scale 16-item; 0-4 scale. Scores can range from 0 to 64 (Higher score means more utilization). Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Primary Composite Sleep Health Score Composite Sleep Health Score which is defined as the sum of scores on 6 sleep health dimensions: Regularity (Midpoint fluctuation), Satisfaction (Sleep quality question on PROMIS-SD), Alertness (Daytime sleepiness question on PROMIS-SRI), Timing (Mean midpoint), Efficiency (Sleep efficiency) and Duration (Total Sleep Time). The Sleep Health Composite was constructed such that higher score indicates better sleep health. Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Primary Composite Scale of Morningness Sum of 13-item; Mix of 4-point and 5-point response scale. Scores can range from 13 (extreme evening) to 55 (extreme morning). Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Primary Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment (PROMIS-SRI) Sum of 8-items rated on a 5-point response scale. Scores can range from 8 to 40 (Higher score means more Sleep Related impairment) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Primary Patient-Reported Outcomes Measurement Information System - Sleep Disturbance (PROMIS-SD) Sum of 8-items rated on a 5-point response scale. Scores can range from 8 to 40 (Higher score means more Sleep Disturbance) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Primary Adapted version of the Work and Social Adjustment Scale A measure of emotional, cognitive, physical, social and behavioral risk. The 5 items are each rated on a 0-8 scale. The 5 individual item scores will be summed into a total score (range: 0 to 40; Higher score means worse outcome). Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary Pittsburgh Sleep Quality Index 19-item. First four items are integer responses. The rest of the items are on a 0-3 scale. Creates 7 composite scores, with the sum of the composite scores ranging from 0 to 21. (Higher score means increased severity of difficulty in all sleep area components). Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary Sleep Diary (Not a scale); Night-to-night variability in the mid-point of sleep Baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary Actigraphy (Not a scale); Night-to-night variability in the mid-point of sleep Baseline to 1-week post treatment
Secondary Depression, Anxiety, and Stress Scale (DASS) Three subscales-depression, anxiety, stress-of 7 items each, ranging from 0-3 per item. Subscale scores range from 0-21. Final scores are multiplied by two. Higher scores mean worse outcomes. Total score will also be calculated. Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary Brief Sensation Seeking Scale 8-item; 5-point response scale; Scores can range from 8 to 40 (Higher score means higher sensation seeking). Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary Physical Health Questionnaire Sum of 15-item, 0-2 response scale. Scores can range from 0 to 30 (Higher score means worse physical symptoms) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary PROMIS-Cognitive Function 6-item; 1-5 response scale. Scores can range from 6-30 (Higher score means better cognitive functioning) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary PROMIS-Ability to participate 4-item; 1-5 response scale. Scores can range from 4-20 (Higher score means better social functioning) Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary Ecological Momentary Assessment Composite Risk Score of Functioning - Emotion (Not a scale) Measured via Ecological Momentary Assessment. a 16-item version of the Positive and Negative Affect Schedule will be administered. The Positivity Ratio will also be calculated. Change from baseline to 1-week post treatment
Secondary Ecological Momentary Assessment Composite Risk Score of Functioning - Cognitive Domain (Not a scale) Measured via Ecological Momentary Assessment. Concentration, distractedness and focus are rated on a 5 point scale. Change from baseline to 1-week post treatment
Secondary Ecological Momentary Assessment (EMA) Composite Risk Score of Functioning - Behavioral Domain (Not a scale) Measured via Ecological Momentary Assessment. The investigators assess eating, caffeine, alcohol, nicotine, marijuana, opioids and prescription and over the counter (OTC) stimulants and sleep aids. Participants will also be asked to list the use of additional psychoactive drugs (e.g. cocaine). The investigators tabulate the average weekly frequency and intake of each substance. Change from baseline to 1-week post treatment
Secondary Ecological Momentary Assessment Composite Risk Score of Functioning - Social Domain (Not a scale) Measured via Ecological Momentary Assessment. will assess if the participant is with anyone at the time of the call. Positivity Ratio (see EMA for Emotional Health) will be calculated when the participant is alone, with a family member or with a friend. Change from baseline to 1-week post treatment
Secondary Ecological Momentary Assessment Composite Risk Score of Functioning - Physical Domain (Not a scale) Measured via Ecological Momentary Assessment. Physical activity and sedentary behaviors will be assessed. Change from baseline to 1-week post treatment
Secondary Self Report Habit Index: Primary habit bundle to build 6 items rated on 1-5 scale. Scores can range from 1 to 30 At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up
Secondary Self Report Habit Index: Primary habit bundle to dismantle 6 items rated on 1-5 scale. Scores can range from 0 to 30 At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up
See also
  Status Clinical Trial Phase
Completed NCT03188263 - Morning Light Treatment to Improve Glucose Metabolism N/A
Recruiting NCT05995132 - Compromised Sleep and Circadian Health After Critical Illness: From Diagnosis to Prediction (CHRONOCRIT)
Completed NCT05070143 - Mini-treatment Experiments to Clarify How to Assist People to Habit Formation N/A
Recruiting NCT03747367 - The Microbiome and Resilience to Sleep and Circadian Disruption N/A
Recruiting NCT02954809 - Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors N/A
Recruiting NCT04364646 - Personalized Integrated Chronotherapy for Perinatal Depression N/A
Withdrawn NCT00907595 - Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon N/A
Completed NCT04373538 - Improving Well-being by Improving Memory for Treatment for Sleep and Circadian Dysfunction N/A
Active, not recruiting NCT03388788 - Body Weight, Sleep, and Heart Health Early Phase 1
Completed NCT03934177 - Impact of Blueberry Consumption on Gastrointestinal Health N/A
Completed NCT02291952 - Development of Countermeasures Against Adverse Metabolic Effects of Shift Work N/A
Completed NCT05263232 - Metabolic Effects of Natural Office Light in Type 2 Diabetes N/A
Recruiting NCT02674230 - OCEAN Registry: Obesity and Clock for Elegant Aging Registry
Recruiting NCT04021355 - Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans N/A
Completed NCT03636360 - The Impact of Artificial Sunlight on Human Sleep and Circadian Rhythms N/A
Recruiting NCT04154631 - Implementing and Sustaining a Sleep Treatment to Improve Community Mental Part 1: Implementation Health Outcomes N/A
Recruiting NCT05986604 - NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment N/A
Completed NCT04111900 - Effect of Sleep on the Recovery of Patients Admitted to the ICU N/A
Completed NCT00492011 - Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers Phase 4
Completed NCT03680989 - A Pilot Test of Mood and Circadian Rhythm Mechanisms Driving Binge Eating N/A